Daniel Clark

Stock Analyst at Leerink Partners

(0.55)
# 3,868
Out of 4,751 analysts
3
Total ratings
n/a
Success rate
-1.6%
Average return

Stocks Rated by Daniel Clark

Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $11.55
Upside: +21.21%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $461.61
Upside: +8.32%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $172.91
Upside: +24.34%